Literature DB >> 15917664

Triple layer control: phosphorylation, acetylation and ubiquitination of FOXO proteins.

Peter K Vogt1, Hao Jiang, Masahiro Aoki.   

Abstract

FOXO proteins are transcriptional regulators that control cell cycle progression, DNA repair, defense against oxidative damage and apoptosis. These divergent functions of FOXO proteins are regulated by signal-induced, post-translational modifications. Phosphorylation of cytoplasmic FOXO at specific sites by JNK initiates translocation into the nucleus. Acetylation and deacetylation of nuclear FOXO affects the selection of transcriptional programs that are controlled by FOXO proteins. Activation of Akt by growth factors results in phosphorylation of nuclear FOXO at specific sites followed by additional phosphorylations mediated by other kinases. Akt-dependent phosphorylation reduces the DNA-binding activity of FOXO, interferes with binding to the co-activators p300/CBP, and inactivates the FOXO nuclear translocation signal. The Akt-phosphorylated FOXO is exported from the nucleus in a CRM1- and 14-3-3-dependent process. Cytoplasmic, Akt-phosphorylated FOXO interacts with the ubiquitin ligase Skp2 and is targeted for proteasomal degradation. The nuclear-cytoplasmic "FOXO shuttle" is driven by stress signals that result in nuclear import and FOXO transcriptional activity and growth signals that initiate nuclear export and proteasomal degradation of FOXO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917664     DOI: 10.4161/cc.4.7.1796

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  116 in total

1.  Synaptic activity and nuclear calcium signaling protect hippocampal neurons from death signal-associated nuclear translocation of FoxO3a induced by extrasynaptic N-methyl-D-aspartate receptors.

Authors:  Oliver Dick; Hilmar Bading
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

2.  Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization.

Authors:  Li Qiang; Alexander S Banks; Domenico Accili
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

3.  Mitochondrial FOXO3a is involved in amyloid β peptide-induced mitochondrial dysfunction.

Authors:  Chun Shi; Jianhua Zhu; Shuilong Leng; Dahong Long; Xiumei Luo
Journal:  J Bioenerg Biomembr       Date:  2016-01-19       Impact factor: 2.945

4.  CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress.

Authors:  Zaher Nahlé; Michael Hsieh; Terri Pietka; Chris T Coburn; Paul A Grimaldi; Michael Q Zhang; Debopriya Das; Nada A Abumrad
Journal:  J Biol Chem       Date:  2008-02-28       Impact factor: 5.157

5.  Conditional switches for extracellular matrix patterning in Drosophila melanogaster.

Authors:  Arvinder Khokhar; Nan Chen; Ji-Ping Yuan; Yishi Li; Gary N Landis; Gregory Beaulieu; Harminder Kaur; John Tower
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

6.  PP2A regulates the pro-apoptotic activity of FOXO1.

Authors:  Ling Yan; Viviana A Lavin; Leta R Moser; Qinghua Cui; Cindy Kanies; Elizabeth Yang
Journal:  J Biol Chem       Date:  2008-01-21       Impact factor: 5.157

Review 7.  Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling.

Authors:  Sebastian Herzog; Michael Reth; Hassan Jumaa
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

8.  Identification of the prosurvival activity of nerve growth factor on cardiac myocytes.

Authors:  A Caporali; G B Sala-Newby; M Meloni; G Graiani; E Pani; B Cristofaro; A C Newby; P Madeddu; C Emanueli
Journal:  Cell Death Differ       Date:  2007-11-09       Impact factor: 15.828

9.  SirT3 regulates the mitochondrial unfolded protein response.

Authors:  Luena Papa; Doris Germain
Journal:  Mol Cell Biol       Date:  2013-12-09       Impact factor: 4.272

10.  CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications.

Authors:  Y-T Tai; Y Landesman; C Acharya; Y Calle; M Y Zhong; M Cea; D Tannenbaum; A Cagnetta; M Reagan; A A Munshi; W Senapedis; J R Saint-Martin; T Kashyap; S Shacham; M Kauffman; Y Gu; L Wu; I Ghobrial; F Zhan; A L Kung; S A Schey; P Richardson; N C Munshi; K C Anderson
Journal:  Leukemia       Date:  2013-04-16       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.